Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Quick-Med Technologies known for developing technologies for the healthcare and consumer markets, has received a seventh US patent for its novel, non-leaching Nimbus antimicrobial technology used in wound care and other medical applications.
Subscribe to our email newsletter
The patent entitled ‘Method of Attaching an Antimicrobial Cationic Electrolyte to the Surface of a Substrate,’ has been granted by the US Patent and Trademark Office (USPTO).
The patent covers the method of production that non-leachably bonds Nimbus antimicrobials to various treated substrates.
The process involves attaching members of the Nimbus family of antimicrobials to substrates that are whole or in part cellulosic or other substrates including polymerics as polyurethane, polyester, nylon and acrylics, as well as silk, linen, rubber, alginates and collagen.
Quick-Med CEO J Ladd Greeno said their non-leachable bonding of the antimicrobial agent distinguishes Nimbus from other antimicrobial materials which require release of the active agent in order to function.